{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-070345","form_type":"8-K","ticker":"CGTX","cik":"0001455365","company_name":"COGNITION THERAPEUTICS INC","filed_at":"2026-06-04T12:00:53+00:00","discovered_at":"2026-06-04T12:05:00.305210+00:00","generated_at":"2026-06-04T12:06:15.878327+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Cognition Therapeutics presents at Jefferies; outlines registrational path for DLB psychosis","bullets":["Cash ~$31.2M as of March 31, 2026; $25.6M remaining NIA grant funds; runway into Q2 2027.","SHIMMER Phase 2: 86% slowing of NPI-12 decline vs placebo; 89% slowing of hallucinations/delusions.","FDA Division of Psychiatry meeting held May 20, 2026; minutes expected June 2026; registrational study design being finalized.","Registrational plan: 9-month, 1:1 zervimesine 100mg vs placebo, endpoint NPI-2; open-label extension planned.","START Phase 2 in early Alzheimer's (545 pts) ongoing; topline data expected 2H 2027."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-070345","json":"https://secwatch.observer/filing/0001104659-26-070345.json","markdown":"https://secwatch.observer/filing/0001104659-26-070345.md","text":"https://secwatch.observer/filing/0001104659-26-070345.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926070345/0001104659-26-070345-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926070345/tm2616896d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T12:06:15.878327+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}